Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Work-site hypertension prevalence and control in three Central European Countries

Abstract

Compared to Austria, cerebrovascular stroke (CVS) mortality is three times higher in Hungary, and twice as high in Slovakia. We hypothesized that this is due to better treatment and control of hypertension in Austria. To test this hypothesis, we carried out a cross-sectional survey of ‘blue collar’ employees on work sites in each of these countries. Blood pressure screening was carried out at three work sites in Austria, one in Hungary and one in Slovakia. A standardized protocol was followed in each of these countries. The Bp-TRUTM measuring instrument was used to provide accurate reproducible readings and eliminate interobserver error. After the exclusion of missing data and women, the study population included 323 males screened in Austria, 600 in Hungary, and 751 in Slovakia. The mean ages of the respondents ranged from 35 to 42 years. The prevalence of hypertension was 29% in Austria, 28% in Hungary and 40% in Slovakia. Of those identified as hypertensive, 73% in Austria, 45% in Hungary and 67% in Slovakia were newly diagnosed as a result of this screening. Of those treated for hypertension, 10% in Austria, 15% in Hungary and 5% in Slovakia were controlled. The differences in CVS mortality cannot be explained by better control of hypertension in Austria but indicate the involvement of other determinants.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. McKee M, Shkolnikov V . Understanding the toll of premature deaths among men in Eastern Europe. Br Med J 2001; 323: 1051–1055.

    Article  CAS  Google Scholar 

  2. Statistics Canada. Canadian statistics information. Accessed May 2002. Available from: URL: http://www.acdi.cida.gc.ca.

  3. World Health Organization, Regional Office for Europe. European health for all database. Accessed January 2002. Available from: URL: http://www.who.dk/hfadb.

  4. Kannel WB . Blood pressure as a cardiovascular risk factor. JAMA 1996; 275: 1571.

    Article  CAS  Google Scholar 

  5. MacMahon S et al. Blood pressure, stroke, coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765.

    Article  CAS  Google Scholar 

  6. Dahlöf B, Devereux RB, Kjeldsen SE . Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995–1003.

    Article  Google Scholar 

  7. Wright JM, Mattu GS . Validation of a new algorithm for the BPM-100 electronic blood pressure monitor. Blood Pressure Monit 2001; 6: 161–165.

    Article  CAS  Google Scholar 

  8. Ginter E . Cardiovascular risk factors in the former communist countries: Analysis of 40 European MONICA populations. Eur J Epidemiol 1995; 11: 199–205.

    Article  CAS  Google Scholar 

  9. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet 2000; 355: 1955–1964.

  10. Joffres M et al. Awareness, treatment and control of hypertension in Canada. Am J Hypertens 1997; 10: 1097–1102.

    Article  CAS  Google Scholar 

  11. Kesteloot H . Regional differences in mortality: a comparison between Austria, Hungary and Switzerland. Acta Cardiol 1999; 54: 299–309.

    CAS  PubMed  Google Scholar 

  12. Mark L, Kondacs A, Hanyecz V . Cardiovascular risk factor profile: Comparison of a Hungarian community with Germany. Wien Klin Wochenschr 1997; 109: 683–687.

    CAS  PubMed  Google Scholar 

  13. Assmann G, Schulte H . The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988; 116: 1713–1724.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge the significant support we have received from Dr A Dukat, Bratislava, Slovakia; Dr T Dorner, Wien, Austria; Dr G Lencse, Szeged, Hungary and Dr M Caprnda, Bratislava, Slovakia. This project was supported by CIDA Canada, the Austrian Red Cross Society, and the City of Wien Healthy Heart Program. The Bp-TRUâ„¢ instruments to all participating sites were donated by Dr Mark Gelfer, Medical Director VSM Corporation, Vancouver, Canada.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J G Fodor.

Appendix A

Appendix A

CLINICAL CHART

Austria–Hungary–Slovakia International Blood Pressure Study See Table A1

Table 6 Table a1

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fodor, J., Lietava, J., Rieder, A. et al. Work-site hypertension prevalence and control in three Central European Countries. J Hum Hypertens 18, 581–585 (2004). https://doi.org/10.1038/sj.jhh.1001685

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001685

Keywords

This article is cited by

Search

Quick links